Table 1.
Basic information of the datasets included in this study.
| Dataset | No. of cases | Gender | Age | T Stage | N Stage | M Stage | Stage | Platform |
|---|---|---|---|---|---|---|---|---|
| TCGA- PDAC | 150 | M: 81 F: 69 | <60: 47, ≥60: 103 | 1-2: 21 3-4: 128 NA: 1 |
0: 39 1: 110 NA: 1 |
0: 68 1: 4 NA:78 |
I/II:142 III/IV:8 |
Illumina |
| Hugo cohort | 26 | NA | NA | NA | NA | NA | NA | Illumina HiSeq2000 |
| Van Allen cohort | 42 | M: 14 F: 28 | <60: 19, ≥60: 23 | NA | NA | 0: 0 1: 42 |
IV: 42 | Illumina |
| ICGC-PACA-AU | 89 | M: 46 F: 43 | <60:21, ≥60: 68 | NA | NA | NA | NA | Illumina HiSeq 2500 |
| GSE21501 | 102 | NA | NA | NA | NA | NA | NA | Agilent- Microarray |
| GSE17891 | 25 | NA | <60: 7, ≥60: 18 | 1-2: 6 3-4: 14 NA: 5 |
0: 6 1: 14 NA: 5 |
0: 20 NA: 5 | I/II: 20 NA: 5 | Affymetrix U133 Plus 2.0 Array |
| GSE28735 | 42 | NA | NA | NA | NA | NA | NA | Affymetrix 1.0 ST Array |
| TCGA-BRCA | 1090 | M: 12 F:1078 | <60: 579, ≥60: 511 | 1–2: 910 3–4: 177 NA: 3 | 0: 514 1–3: 556 NA:20 |
0: 907 1:22 NA:161 | I/II:798 III/IV:268 NA: 24 | Illumina |
| TCGA-COADREAD | 373 | M: 206 F: 167 | <60: 129, ≥60: 244 | 1–2: 67 3–4: 305 NA: 1 |
0: 205 1-2: 165 NA: 3 |
0: 252 1: 51 NA:70 |
I/II: 191 III/IV:164 NA: 18 | Illumina |
M: Male; F: Female; NA: Not Available.